policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
AVMA news
Animal blood shortage deepens during pandemic
Veterinarians struggle to acquire adequate blood supplies as transfusions become more routine and donations decline. Meanwhile, California is…
JAVMA news
Researchers hope for blood-based canine cancer test in 2020
Company backing the technology struggles amid push for test validation
JAVMA news
Large animal practitioners grapple with fluid shortage
Large animal practitioners are grappling with a shortage of large-volume bags of polyionic fluids, separate from the ongoing shortage
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
JAVMA news
In Short
Aquarium cleaner death, anxiety in dogs, and more in the May 1 “In Short” section
JAVMA news
Candidate vaccine protects pigs against African swine fever strains
A U.S. Department of Agriculture–developed vaccine against African swine fever protected pigs in a second study, suggesting progress toward a…
JAVMA news
Katrina: stories from the storm
A decade has passed since Hurricane Katrina hit New Orleans on Aug. 29, 2005, breaking levees and flooding much of the area.